Revolution Medicines, Inc. (NASDAQ:RVMD) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Peg Horn - Chief Operating Officer Mark Goldsmith - Chairman & Chief Executive Officer Jack Anders - Senior Vice President of Finance & Principal Accounting Officer Steve Kelsey - President of R&D Conference Call Participants Michael Schmidt - Guggenheim Jonathan Chang - SVB Leerink Eric Joseph - JPMorgan Marc Frahm - Cowen & Company Chris Shibutani - Goldman Sachs Benjamin Burnett ...